Apr 09, 2020
York based rapid test developer and manufacturer, Abingdon Health, announces its membership of the UK Rapid Test Consortium. A consortium formed in response to UK Government's request to increase COVID-19 testing.
Apr 02, 2020
Abingdon Health and DCN Diagnostics have announced a commercial partnership to provide Abingdon Health's proprietary AppDx Smartphone m-Health technology to DCN Diagnostics' customer base.
Mar 12, 2020
In situations such as the coronavirus outbreak there is a potential for rapid test supply to fall behind demand. This is where a second manufacturer can address this issue.
Jan 21, 2020
Following a successful 2019, Abingdon Health is expanding its York-based facility, giving the company the space and capabilities necessary to continue to drive forward rapid diagnostic testing innovation and growth.
Dec 06, 2019
In a recent CCLM publication, the authors concluded that Seralite® FLC Serum, a quantitative lateral flow immunoassay, has shown good clinical concordance when compared with other sFLC assays.
Nov 13, 2019
Octylphenol ethoxylates (OPE) are now in the Annex XIV of REACH. Why do OPEs feature in this list and what does it mean for lateral flow rapid tests that use OPEs, such as Triton-X?
Nov 05, 2019
'85% of all clinical trials fail to recruit enough patients and 80% are delayed due to recruitment problems and dropout rates are high' (Source: biopharmadive.com).
Oct 21, 2019
Abingdon Health is pleased to announce 121 demonstrations of its AppDx lateral flow Smartphone reader are now available by appointment.
Oct 09, 2019
Patient participation is a fundamental requirement to the overall success of clinical trials. So, lateral flow based mHealth technology needs to be utilised to overcome clinical trial patient recruitment and retention issues.
Oct 08, 2019
A transformation that goes straight to your business' bottom line